Clinical Trial Update: FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation [NA]

View source ↗

Summary

A first-in-human ITA study is evaluating the Vesalius TMVr System for symptomatic degenerative mitral regurgitation; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Mitral Regurgitation

Drugs mentioned

• Vesalius TMVr System

Snippet

Sponsor: Vesalius Cardiovascular Inc. | Conditions: Degenerative Mitral Regurgitation | NA | Status: NOT_YET_RECRUITING